This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Therapeutic Drug Monitoring Markets

NEW YORK, March 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Therapeutic Drug Monitoring Markets

http://www.reportlinker.com/p01138847/Therapeutic-Drug-Monitoring-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Therapeutic drug monitoring (TDM) is an important clinical assessment of drug plasma concentrations that also yields information regarding the efficacy, toxicity levels and potential drug-drug interactions of agents with a narrow therapeutic index. Ultimately, therapeutic drug monitoring testing provides clinical information to optimize dosage regimes and prevent adverse reactions and lack of treatment compliance.

This TriMark Publications report analyzes the therapeutic drug monitoring market and the various market segments within it, e.g., antiepileptics, antiarrhythmics, antibiotics, antineoplastics, bronchodilators, immunosuppressives and HIV/AIDS drugs. The report also examines drug analysis technology platforms, clinical applications of therapeutic drug testing and the market for quantitative diagnostic drug tests. Moreover, the study analyzes almost all of the companies known to be marketing, manufacturing or developing therapeutic drug monitoring products in the U.S. and worldwide. Detailed tables and charts with sales forecasts and marketshare data are also included.

TABLE OF CONTENTS

1. Overview 9

1.1 Statement of Report 9

1.2 About This Report 9

1.3 Scope of the Report 10

1.4 Objectives 10

1.5 Methodology 11

1.6 Executive Summary 12

2. Therapeutic Drug Monitoring 162.1 Introduction 162.2 Function of Therapeutic Drug Monitoring 182.3 Drug Screening Boom 202.3.1 Pain Management Drug Testing in Europe 222.3.2 Neonate Patients and Patients of Old Age 222.3.3 Therapeutic Drug Monitoring and Immunosuppressive Drugs 232.3.4 Antiretroviral Usage and TDM Monitoring 232.4 The Process of Therapeutic Drug Monitoring 25

3. Commonly Monitored Therapeutic Drugs 29

3.1 Antiepileptics 30

3.2 Antiarrhythmics 32

3.3 Antimanics 35

3.4 Antineoplastic Drugs (Anticancer Drugs) 37

3.5 Bronchodilators 39

3.6 Antibiotics 40

3.7 Immunosupressants 41

3.7.1 Interference in Immunosuppressant Drug Immunoassays1 42

1 of 10

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs